AMITRIPTYLINE HYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

amitriptyline hydrochloride tablet, film coated

advagen pharma ltd - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardial infarc

AMITRIPTYLINE HYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

amitriptyline hydrochloride tablet

rising pharma holdings, inc. - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardial infarc

Amitriptyline hydrochloride 10mg/5ml Oral solution United Kingdom - English - myHealthbox

amitriptyline hydrochloride 10mg/5ml oral solution

wockhardt uk ltd - amitriptyline hydrochloride - oral solution - 10 mg/5ml - it is indicated for the treatment of: symptoms of depression (especially where sedation is required); nocturnal enuresis where organic pathology is excluded.

NortriTABS nortriptyline (as hydrochloride) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

nortritabs nortriptyline (as hydrochloride) 10 mg uncoated tablet bottle

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 11.4 mg (equivalent: nortriptyline, qty 10 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - treatment of major depression

NortriTABS nortriptyline (as hydrochloride) 25 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

nortritabs nortriptyline (as hydrochloride) 25 mg uncoated tablet bottle

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 28.5 mg (equivalent: nortriptyline, qty 25 mg) - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate - treatment of major depression

Amitriptyline 25mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

amitriptyline 25mg tablets

a a h pharmaceuticals ltd - amitriptyline hydrochloride - oral tablet - 25mg